Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome

被引：0
|
作者：
Ignatova, G. [1 ]
Blinova, E. [1 ]
机构：
[1] South Ural State Med Univ, Therapy, Chelyabinsk, Russia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3322
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Metabolic syndrome in chronic obstructive pulmonary disease
    Zaibi, Haifa
    Maazaoui, Sarra
    Ben Amar, Jihen
    Laaouini, Ines
    Azzebi, Saloua
    Baccar, M. Ali
    Dhahri, Besma
    Aouina, Hichem
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [42] Therapeutic Efficacy of Topical Phosphodiesterase-4 Inhibitor in Murine Dry Eye Disease
    Okanobo, A.
    Chauhan, S.
    Chen, Y.
    Zhang, Q.
    Dana, R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [43] Effects of Roflumilast on Chronic Bronchitis Symptom in Patients of Chronic Obstructive Pulmonary Disease
    Joo, H.
    Kim, J.
    Kim, K.
    Kyu, Y. Hyoung
    Rhee, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [44] Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients
    Liu, Dong-yang
    Wang, Zhi-guo
    Gao, Yuan
    Zhang, Hui-min
    Zhang, Yu-xiang
    Wang, Xiao-jun
    Peng, Dan
    MEDICINE, 2018, 97 (07)
  • [45] Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
    Ostrovskyy, Mykola
    Savelikhina, Iryna
    Ostrovska, Kseniia
    Varunkiv, Oleksandr
    Kulynych-Miskiv, Mariana
    Korzh, Galyna
    Shvets, Kostiantyn
    Korzh, Nadiia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [46] Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
    Kim, Kyung Hoon
    Kang, Hye Seon
    Kim, Ju Sang
    Yoon, Hyoung Kyu
    Kim, Sung Kyoung
    Rhee, Chin Kook
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3449 - 3456
  • [47] Correction of Metabolic Syndrome in Patients With Severe Chronic Obstructive Pulmonary Disease
    Ignatova, G. L.
    Belsner, M. S.
    Blinova, E. V.
    KARDIOLOGIYA, 2015, 55 (02) : 57 - 59
  • [48] Metabolic syndrome and systemic inflammation in patients with chronic obstructive pulmonary disease
    Hosny, H.
    Abdel-Hafiz, H.
    Moussa, H.
    Soliman, A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2013, 62 (01): : 85 - 89
  • [49] Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome
    Naseem, Sufia
    Baneen, Ummul
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (10) : 3393 - 3398
  • [50] Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
    Singh, D.
    Govoni, M.
    Beeh, K. M.
    Colgan, B.
    Kornmann, O.
    Leaker, B.
    Watz, H.
    Lucci, G.
    Geraci, S.
    Rocco, E. Calabro
    Emirova, A.
    Nandeuil, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345